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Abstract Uric acid and ascorbic acid are important low
molecular weight antioxidants in plasma. Their interactions
and combined effect on Cu2+-catalysed oxidation of human low
density lipoprotein were studied in vitro. It was found that uric
acid alone becomes strongly prooxidant whenever it is added to
low density lipoprotein shortly after the start of oxidation
(conditional prooxidant). Ascorbic acid, which is present in
human plasma at much lower concentrations (20^60 WM) than
urate (300^400 WM), is in itself not a conditional prooxidant.
Moreover, ascorbate prevents prooxidant effects of urate, when
added to oxidising low density lipoprotein simultaneously with
urate, even at a 60-fold molar excess of urate over ascorbate.
Ascorbate appears to have the same anti-prooxidant effect with
other aqueous reductants, which, besides their antioxidant
properties, were reported to be conditionally prooxidant. Such
interactions between ascorbate and urate may be important in
preventing oxidative modification of lipoproteins in the circula-
tion and in other biological fluids.
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1. Introduction
Oxidation of low density lipoprotein (LDL) has been sug-
gested to play a key role in the development of atherosclerosis
and as a consequence an important role in the prevention of
LDL oxidation has been attributed to the antioxidants con-
tained within LDL and in plasma (for a review see [1]). The
major low molecular weight antioxidants in plasma are urate
(UA, 300 WM, approximately) and ascorbate (AA, 20^60 WM,
approximately) [1,2], and they appear to be mainly responsible
for the fact that only very small amounts of oxidised LDL are
found in the circulation. Recently, many aqueous antioxi-
dants/reductants were found to promote metal-catalysed oxi-
dation of LDL, whenever the major endogenous antioxidant
of LDL, K-tocopherol, has been already consumed. The list of
substances capable of such redox activation of transition met-
als includes trolox [3], a water soluble analogue of K-toco-
pherol, dehydroascorbate (DHA) [4^6], £avonoids [5], antho-
cyanins [7], catechins [8] and a variety of other aqueous re-
ductants. AA has been reported to act likewise [4,5], and
prooxidant e¡ects have also been observed in vivo [9], but
other reports [6,10] have left some doubt regarding prooxi-
dant e¡ects of AA in LDL oxidation. This is even more re-
markable as in metal-containing solutions, AA is rapidly con-
verted to DHA. However, DHA derived from AA during
Cu2-catalysed oxidation of LDL does not become prooxi-
dant [4,5], suggesting a more general ability of AA to prevent
prooxidant e¡ects of antioxidants.
In this paper we report prooxidant properties of UA, in
Cu2- catalysed LDL oxidation and the ability of AA to
counteract the prooxidant e¡ects of UA.
2. Materials and methods
Ascorbic acid was from Loba (Fischamend, Austria), dehydroas-
corbate was from Sigma (Vienna, Austria), all other chemicals used
were from Merck or Sigma (Vienna, Austria) and of analytical grade
or better.
2.1. LDL preparation
LDL was prepared from pooled EDTA plasma of healthy volun-
teers of both sexes by ultracentrifugation in a single step discontinu-
ous gradient in a Beckman NVT65 rotor, as described [11]. Prior to
use, LDL was stored in an evacuated glass vial under argon at 4‡C for
a maximum of 2 weeks. The LDL concentration was determined from
its cholesterol content, using the CHOD-PAP enzymatic test kit
(Boehringer-Mannheim, Germany), assuming a molar mass of LDL
of 2.5 MDa and a cholesterol content of 32.2 weight%.
2.2. LDL oxidation
Prior to oxidation of LDL, EDTA and KBr were removed by
gel¢ltration as described [12]. Unless indicated otherwise, oxidation
was performed at 37‡C by addition of a 100 WM solution of CuSO4 to
a 0.1 WM solution of LDL in PBS (160 mM NaCl, 10 mM Na-phos-
phate, pH = 7.4) to give a ¢nal concentration of 1.6 WM Cu2. The
progress of oxidation was monitored spectrophotometrically (Beck-
man DU-640, equipped with Peltier-thermostatted six cell holder) by
the formation of conjugated dienes at 234 nm (A234) [12]. Lag-times of
LDL oxidation were determined as the time coordinate of the inter-
section of the tangents to the slow and fast phases of conjugated diene
formation. Solutions of aqueous antioxidants in PBS were added pri-
or to addition of copper, or at the indicated time points, to give the
indicated concentrations.
2.3. Low level chemiluminescence (LL-CL) measurements
LL-CL was measured in a LUCY I luminometer (Anthos Labtech
Instruments, Salzburg, Austria) equipped with a single photon count-
ing photomultiplier (sensitivity 300^700 nm) as described [13]. The
integration time was set to 90 s, measurements were performed in a
white microplate. LL-CL is due to the termination of peroxyl radicals
and formation of excited oxygen species (in this case mostly triplet
carbonyls are monitored [13]) which emit light upon return to the
ground state. The intensity of LL-CL corresponds to the square of
the oxidation rate.
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3. Results
3.1. Antioxidant and prooxidant e¡ects of urate on the LDL
oxidation
Incubation of 0.1 WM LDL with 1.6 WM Cu2 in the pres-
ence of 20 WM UA (at t = 0 min) led to a considerable pro-
longation of the lag-phase (typically from 60 min to 150 min)
(Fig. 1 shows one representative experiment of four). Addition
of UA at later time points, when oxidation had already
started and the K-tocopherol content of LDL was reduced
or already exhausted (30 min under these experimental con-
ditions, compare [3]) led to a considerable reduction of the
lag-time or even to the immediate start of the propagation
phase. After addition of UA, the maximal oxidation rate dur-
ing propagation was strongly increased compared to the con-
trol (the immediate increase in absorbance after addition is
due to UA).
3.2. AA, but not DHA prevents prooxidant e¡ects of UA
When 0.1 WM LDL was oxidised by 1.6 WM Cu2 in the
presence of 20 WM AA plus 20 WM UA (mixed before addi-
tion), no prooxidant e¡ect of UA, as shown in Fig. 1, could
be observed, irrespective of the time point of addition (Fig.
2A). Addition of a combination of 20 WM AA and UA at t = 0
min produced a very long lag-phase (450 min), which was
about halved when AH and UA were added at t = 30 min,
but still much longer than the control. In order to check
whether this anti-prooxidant e¡ect of AH extends to other
aqueous reductants, we repeated the experiment using 3 WM
of trolox, a water soluble analogue of K-tocopherol, which has
been shown previously to be a conditional prooxidant [3], and
found a similar behaviour (not shown).
Fig. 2B shows that DHA does not exert anti-prooxidant
e¡ects. Rather, addition of 20 WM DHA and 20 WM UA at
t = 30 min produced an even stronger prooxidant e¡ect on the
LDL oxidation. Note also that the antioxidant e¡ect of
DHA+UA at t = 0 is about the same as AH+UA at t = 30
min.
3.3. Anti-prooxidant e¡ect of 20 WM AA at 300 WM UA
In human plasma, the concentrations of UA are much high-
er than those of AA. In order to investigate the anti-proox-
idant e¡ect of AA in presence of a large excess of UA, LL-CL
was used to monitor the oxidation, due to the strong UV
absorbance of UA.
In this experiment, 0.3 WM LDL was incubated with 4.8 WM
of Cu2. Fig. 3 shows that the presence of 20 WM AA and/or
300 WM UA at t = 0 led to a practically complete suppression
of the LDL oxidation (longer than 800 min in these experi-
ments). Addition of 300 WM UA at t = 35 min led to an im-
mediate increase of LL-CL, consistent with the prooxidant
e¡ect of UA observed already for 20 WM UA, by monitoring
the conjugated diene formation (Fig. 1). Note that the max-
imum rate of oxidation is about four-fold higher (two-fold
higher LL-CL, [13]) due to the prooxidant e¡ect of UA. Si-
multaneous the addition of 20 WM AA and 300 WM UA at 35
min, however, prevented a signi¢cant increase in LL-CL.
Rather, LDL oxidation was suppressed for more than 800
min, similar to the e¡ect of 300 WM UA added at t = 0.
Even at a much higher Cu2 concentration (167 WM), the
simultaneous addition of AA and UA led only to a small
oxidative burst (data not shown), corresponding to about
10% of the rate produced by adding UA alone at 35 min.
4. Discussion
4.1. Antioxidant and prooxidant properties of UA
Fig. 1 shows that UA is not only a good antioxidant in
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Fig. 1. Antioxidant and prooxidant e¡ect of UA in LDL oxidation.
A 0.1 WM solution of LDL was oxidised with 1.6 WM Cu2, moni-
toring the A234, in the absence (control) or presence of 20 WM UA.
UA was either present from the beginning (0) or added at the indi-
cated time points. The immediate increase of A234 (0.3C0.55) after
addition of UA is due to UA itself.
Fig. 2. E¡ects of AA and DHA on the prooxidant e¡ect of UA.
LDL (0.1 WM) was oxidised with 1.6 WM Cu2 (control) and the
A234 monitored. A: a mixture of 20 WM AA and 20 WM UA was
present from the beginning of oxidation (0) or added at 30 min
(30). B: the procedure as in A, but 20 WM DHA was used instead
of AA.
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metal-catalysed LDL oxidation but that it also shares, with
many aqueous antioxidants, the property of switching to a
prooxidant mode whenever added after (partial) depletion of
K-tocopherol (conditional prooxidant). The prooxidant poten-
tial of UA appears to be quite high, compared to other condi-
tional prooxidants: only 10 min after oxidation (during which
time about one third of the K-tocopherol content is lost under
our experimental conditions (compare [3])), UA already acts
as a prooxidant, whereas most other water soluble reductants
become prooxidant only when most or all of the K-tocopherol
in LDL has been consumed (compare [3^5,7^9]).
4.2. Exclusively antioxidant and anti-prooxidant properties of
AA but not DHA
AA appears to have very particular antioxidant properties,
as it is the only aqueous antioxidant described so far which is
not a conditional prooxidant [4,6] in the Cu2-mediated oxi-
dation of LDL. This is even more surprising, as brief incuba-
tion with transition metal ions is su⁄cient to convert AA to
DHA, which itself is a conditional prooxidant.
The antioxidant properties of AA have been attributed
largely to its ability to reduce a K-tocopheroxyl radical back
to K-tocopherol (reviewed in [14]). However, AA is an ex-
tremely e¡ective antioxidant even after consumption of K-to-
copherol (and thus of K-tocopheroxyl radical) in LDL, rather
than becoming prooxidant: its antioxidant e¡ect is concentra-
tion-dependent (unpublished data, [4,5]).
4.3. Possible mechanism of prooxidant e¡ects of aqueous
reductants
Consistent with experimental data, the prooxidant proper-
ties of water soluble antioxidants can be attributed to an en-
hancement of redox cycling of transition metal ions at a lipid-
aqueous phase boundary:Cu2+LOOHCCu+LOOc+H
(lipid phase, slow) (1)Cu+LOOHCCu2+LOc+OHÿ (lipid
phase, fast) (2)Cu2+RedHCCu+Redc+H (aqueous phase,
fast) (3)In this reaction scheme, the slow, rate limiting reduc-
tion of Cu2 by lipid hydroperoxides (LOOH, reaction 1) is
enhanced by the reduction of Cu2 through an aqueous re-
ductant (RedH, reaction 3).
As long K-tocopherol is present in LDL, which itself acts as
a prooxidant by reducing Cu2 [15,16], such an enhanced
reduction has no observable e¡ects because K-tocopherol
and K-tocopheroxyl radical can both scavenge the lipid radi-
cals generated.
4.4. Possible mechanisms of the anti-prooxidant action of AA
There are several possible explanations for this peculiar
anti-prooxidant e¡ect of AA: (i) It has been suggested that
the urate radical, formed by oxidation of UA with Cu2 [17]
could re-initiate lipid peroxidation. AA would then scavenge
such radicals. However, the anti-prooxidant e¡ect of AA in-
cludes not only UA but also AA and Trolox, the radicals of
which have di¡erent reactivities. Moreover, such a re-initia-
tion by antioxidant radicals is inconsistent with the good anti-
oxidant properties of these substances in the presence of Toc-
OH (compare also (iii)). (ii) We could rule out the possibility
that AA is able to regenerate TocOH even after its complete
consumption. (iii) It appears reasonable that AA is able to
redox inactivate LOOH and keeps the metal in the reduced
state (eq. (3)), which would e¡ectively prevent redox cycling.
This is corroborated by the observation that higher concen-
trations of UA in combination with AA lead to a better anti-
oxidant e¡ect even under conditions where UA alone is
prooxidant (compare Figs. 2 and 3). This also contradicts
(i). (iv) It has been reported that the formation of 2-oxo-his-
tidine residues on apoB-100 might reduce copper binding and
hence be in part responsible for the fact that AA does not
become prooxidant. However the modifying agent in [6] ap-
pears to be DHA and not AA. Moreover, preincubation of
LDL with either AA or DHA (data not shown) failed to
render LDL insensitive to the prooxidant behaviour of UA.
It is conceivable, however, that histidine residues [10,18], cop-
per, LOOH and AA act together in this anti-prooxidant e¡ect.
4.5. Conclusion
AA appears to be an e¡ective anti-prooxidant even in the
presence of a large excess of UA, at concentrations of AA
which are at the lower boundary of ‘normal’ AA concentra-
tions in human plasma (Fig. 3). Apparently, AA does not
simply compete with the prooxidant, it rather leads to very
e¡ective uncoupling of metal reduction from radical forma-
tion.
The anti-prooxidant property of AA is particularly impor-
tant in the light of increasingly frequent reports about condi-
tionally prooxidant properties of many powerful antioxidants
in LDL oxidation. Under circumstances, such as moderate
depletion of endogenous antioxidants in lipoprotein, the ur-
ate-ascorbate system in human plasma appears to be quite
‘well-designed’ to preserve their integrity.
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